Literature DB >> 4005953

Enhancement of RNA polymerase III transcription by the E1A gene product of adenovirus.

W K Hoeffler, R G Roeder.   

Abstract

Nuclear extracts from adenovirus-infected HeLa cells harvested early in infection demonstrated a markedly increased capacity for transcription by RNA polymerase III of exogenous VA RNA genes, as well as cloned tRNA and 5S RNA genes. In contrast, no enhanced transcription was observed in extracts from cells infected with an E1A deletion mutant. Moreover, cells co-transfected with the VA- and E1A-containing plasmids showed markedly higher levels of VA RNA synthesis than did cells transfected with the VA-containing plasmid alone. Although analysis of high ionic strength extracts revealed that the enhancement of pol III transcription persists late in infection, moderate ionic strength extracts indicated that transcription factor IIIC becomes limiting. Chromatographic fractionation and complementation analysis of extracts from mock- and virus-infected cells indicated that the factor(s) responsible for the enhanced activity was localized entirely in the fraction containing transcription factor IIIC.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4005953     DOI: 10.1016/s0092-8674(85)80076-3

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  95 in total

Review 1.  RNA polymerase III transcription: its control by tumor suppressors and its deregulation by transforming agents.

Authors:  T R Brown; P H Scott; T Stein; A G Winter; R J White
Journal:  Gene Expr       Date:  2000

2.  Alternate translation initiation on hepatitis B virus X mRNA produces multiple polypeptides that differentially transactivate class II and III promoters.

Authors:  L Kwee; R Lucito; B Aufiero; R J Schneider
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

3.  Purification of the heteromeric protein binding to the URS1 transcriptional repression site in Saccharomyces cerevisiae.

Authors:  R M Luche; W C Smart; T G Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

4.  A transcriptionally active form of TFIIIC is modified in poliovirus-infected HeLa cells.

Authors:  M E Clark; A Dasgupta
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

5.  Phosphorylation-dependent activation of the adenovirus-inducible E2F transcription factor in a cell-free system.

Authors:  S Bagchi; P Raychaudhuri; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

6.  E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor.

Authors:  S W Hiebert; M Lipp; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

7.  The adenovirus-inducible factor E2F stimulates transcription after specific DNA binding.

Authors:  A S Yee; P Raychaudhuri; L Jakoi; J R Nevins
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

8.  Upstream DNA sequences determine different autoregulatory responses of the adenovirus types 5 and 3 E1A promoters.

Authors:  S N Jones; C Tibbetts
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

9.  Genetic dissection of the transactivating domain of the E1a 289R protein of adenovirus type 2.

Authors:  M L Fahnestock; J B Lewis
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

10.  Activation of RNA polymerase III transcription of human Alu repetitive elements by adenovirus type 5: requirement for the E1b 58-kilodalton protein and the products of E4 open reading frames 3 and 6.

Authors:  B Panning; J R Smiley
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.